Form 4 for CNMD CONMED Corp
Accepted 2021-11-05 00:00:00 ET · period of report 2021-11-04 · accession 0001127602-21-028434 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-05 | 2021-11-04 | CNMD | Peters Stanley W III | VP GM Advanced Surgery | M - OptEx | $39.87 | +14.0K | 14.1K | +22,222% | +$558.2K |
| D | 2021-11-05 | 2021-11-04 | CNMD | Peters Stanley W III | VP GM Advanced Surgery | S - Sale+OE | $154.06 | -14.0K | 63 | -100% | -$2.16M |
| D | 2021-11-05 | 2021-11-04 | CNMD | Peters Stanley W III | VP GM Advanced Surgery | M - OptEx | $0.00 | -14.0K | 2,700 | -84% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-04 | M | A | 14,000 | $39.87 | 14,063 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-04 | S | D | 14,000 | $154.06 | 63 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.00 to $154.58. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 3 | Derivative | Options To Purchase Common Stock | 2021-11-04 | M | D | 14,000 | $0.00 | 2,700 | D | $39.87 · — to 2026-03-01 | 14,000 Common Stock | (F2) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |